1. Home
  2. RSS Feeds
September 22,2026
Pharming announces positive Phase II top
September 22,2026
[Ad hoc announcement pursuant to Art. 53
September 22,2026
Respiree Extends Series A Syndicate with
September 22,2026
Onco360® is a participating specialty p
September 22,2026
Anaptys Announces Second Quarter and Tra
September 22,2026
Abivax Presents Business Updates and Fir
September 22,2026
Mineralys Therapeutics Reports Inducemen
September 22,2026
TestoPrime 2026: Announces Updated Testo
ALZ-101, Alzinova’s therapeutic vaccine candidate for Alzheimer’s disease.
September 21,2026
Alzinova Advances Dual Approach to Alzhe
September 21,2026
Cullinan Therapeutics to Participate in
September 21,2026
European Commission approves Roche’s S
September 21,2026
Zealand Pharma - Transactions related to
September 21,2026
Leads Biolabs’ Pivotal Phase IIb Study
September 21,2026
Transactions under Novonesis’ share bu
September 21,2026
European Commission approval of ICOTYDEâ
September 21,2026
Avalyn Publishes Phase 1 Data Highlighti
September 21,2026
NewAmsterdam Pharma and Menarini Group R
September 21,2026
Palisade Bio to Present at Stifel 2026 V
September 21,2026
Novo Nordisk A/S - share repurchase prog
September 21,2026
Clene Announces Closing of $4 Million Re
September 21,2026
NeOnc Charting New Nasal Route to Treati
September 21,2026
Change to American Depositary Share Rati
September 21,2026
Medicus Pharma Announces Exclusive Devel
September 21,2026
InflaRx to Host Virtual Capital Markets
September 21,2026
Dr. Maximilian Doebler appointed Chief E
September 21,2026
Beacon Therapeutics Reports Positive Top
September 21,2026
Vironexis Announces Complete and Durable
September 21,2026
Seer Announces CFO Transition
September 21,2026
Tiziana Announces Last Patient Completes
September 21,2026
Novo's CagriSema delivers superior weigh
September 21,2026
Highlights to be presented at Novo’s C
September 21,2026
Bavarian Nordic – Transactions in Conn
September 21,2026
Beacon Therapeutics Reports Positive Top
September 21,2026
Telix and ITM Join Forces to Create a Ra
September 20,2026
Cue Biopharma Announces Positive Topline
September 19,2026
Iovance Biotherapeutics Reports Induceme
September 19,2026
New Teva Study Identifies the Attributes
September 19,2026
Teva Highlights New Real-World Data Show
September 19,2026
Teva Announces New Olanzapine LAI (TEV-'
September 19,2026
NurExone Expands U.S. Engagement Across
Industries
Visitor Count 86058